MedPath

RIFATER

RIFATER

Discontinued
DIN Number

02148625

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02148625
AIG Number0327238001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04AM05 RIFAMPICIN, PYRAZINAMIDE AND ISONIAZID
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification08:16.04
Health Canada Classification

ACTIVE INGREDIENTS (3)

ISONIAZIDActive
Strength: 50 MG
Monograph: ISONIAZID
PYRAZINAMIDEActive
Strength: 300 MG
Monograph: PYRAZINAMIDE
RIFAMPINActive
Strength: 120 MG
Monograph: RIFAMPIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.